Ascendis Pharma A/S announced that Thomas P. Soloway has been appointed Chief Financial Officer. Mr. Soloway joins the company after holding the positions of Chief Financial Officer and Chief Operating Officer at Transcept Pharmaceuticals Inc. Mr. Soloway joins Ascendis from Transcept Pharmaceuticals Inc. where he was a co-founder of the company and served initially as Chief Financial Officer and later as Executive Vice President and Chief Operating Officer. In these roles, Mr. Soloway led all investor relations activities and was a key member of the executive management team overseeing clinical development, regulatory affairs, pharmaceutical sciences, manufacturing and all financial activities.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
124.3 USD | -2.60% | -5.30% | -1.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.14% | 7.32B | |
+17.02% | 124B | |
+18.79% | 112B | |
+3.52% | 22.94B | |
-11.80% | 17.02B | |
-16.50% | 16.88B | |
-39.57% | 16.87B | |
+3.57% | 13.63B | |
+24.08% | 11.61B | |
+106.13% | 10.31B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- Ascendis Pharma A/S Announces Appointment of Thomas P. Soloway as Chief Financial Officer